Decode Genetics Inc & Arup Laboratories

U.S. Laboratories and Physicians Will be Able to use Their ARUP Accounts to Order deCODE's Test for Assessing Risk of Prostate Cancer

Older News

Reykjavik, ICELAND, and Salt Lake City, UTAH, July 20, 2010 - deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE's DNA-based prostate cancer risk assessment test to its clients nationwide.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy